Florida Senate Bill 1602 (Prior Session Legislation)

---

Completed Legislative Action
Spectrum: Partisan Bill (Republican 1-0)
Status: Failed on May 3 2019 - 100% progression
Action: 2019-05-03 - Died in Health Policy
Text: Latest bill text (Introduced) [HTML]

Requiring cancer clinical trial programs to inform prospective patient subjects of the specified reimbursements for ancillary costs and travel expenses which may be available to them and their caregivers if they participate in a cancer clinical trial; specifying that reimbursement offers may not be coercive or exert an undue influence and are not considered inducements for participation; requiring certain entities that offer reimbursement programs to secure the informed consent of patient subjects, etc.

Cancer Clinical Trials

Sen. David Simmons [R]

Date	Chamber	Action
2019-05-03	Senate	Died in Health Policy
2019-05-03	Senate	Indefinitely postponed and withdrawn from consideration
2019-03-13	Senate	Introduced
2019-03-08	Senate	Referred to Health Policy; Banking and Insurance; Rules
2019-03-01	Senate	Filed

Chapter	Article	Section	Citation Type	Statute Text
385	2021		Amended Code	See Bill Text

Type	Source
Summary	https://www.flsenate.gov/Session/Bill/2019/1602
Text	https://www.flsenate.gov/Session/Bill/2019/1602/BillText/Filed/HTML